In vitro studies suggest that HCC cell lines are also susceptible to PARP inhibition (47), corresponding to elevated levels of PARP1/2 enzymes and PARylation in HCC tissues (48, 49). The gene discussed is PARP1; the disease is hepatocellular carcinoma.